Equity Analyst, LightStream Research

Shifara Samsudeen, FCMA, CGMA

A chartered management accountant with more than 10 years of rich experience in investment research and financial analysis. Worked as an equity analyst for one of the world's largest asset managers with USD2.5trn in AUM covering numerous sectors including chemicals, retail, tech, autos, telco, real-estate and banks, globally. Experienced in fundamental equity research, industry research, commodity studies, forensic accounting, and due diligence reviews.

Equity Analyst

Zhangmen Education IPO: Risks Outweigh the Very Few Positives

Angelalign IPO Valuation: Limited Upside from the Top End

Full Truck Alliance IPO: In Early Stage of Monetisation

Baidu 1Q21: Post-Pandemic Recovery in Online Marketing and New Initiatives Drive Earnings Beat

JD Logistics: Margins Sink as JDL Prioritises Market Share but Peer Margins Shrink Too in 1Q21

Tencent: Earnings Beat Consensus; Falling User Growth and Game Revenue Growth Concerning

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Capital Markets

Angelalign Technology  / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/angelalign-technology-inc" target="_blank" data-smartkarma-citation="entities:31480:1" rel="noopener">Angelalign Technology (AAT HK)</a>  is one of the leading clear aligner treatment solution providers in China. The company has filed for an IPO to list its shares on the Hong Kong Stock Exchange and plans to raise proceeds of approx. US$300m.</p><p>The clear aligner treatment market in China is highly concentrated with the top two players controlling approx. 82.4% of the market in 2020. Based on shipment volume, the company was ranked the second largest player with a market share of 41.0% in 2020.</p>

Angelalign Technology (AAT HK)  is one of the leading clear aligner treatment solution providers in China. The company has filed for an IPO to list its shares on the Hong Kong Stock Exchange and plans to raise proceeds of approx. US$300m.The clear aligner treatment market in China is highly concentrated with the top two players controlling approx. 82.4% of the market in 2020. Based on shipment volume, the company was ranked the second largest player with a market share of 41.0% in 2020.

Angelalign Technology IPO: No Misalignment